Benitec Biopharma Inc. (BNTC) Social Stream
Benitec Biopharma Inc (BNTC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Benitec Biopharma Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued February 17, 2022
BNTC Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, Benitec Biopharma Inc's number of analysts covering the stock is greater than practically none of them.
- In terms of how Benitec Biopharma Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than just about 100% of that group.
- In terms of how Benitec Biopharma Inc fares relative to Healthcare stocks, note that its average analyst price target is greater than 15.2% of that group.
- In the context of Healthcare stocks, Benitec Biopharma Inc's upside potential (average analyst target price relative to current price) is greater than 76.54% of them.
Make investment decisions regarding BNTC using the data that counts. Try POWR Ratings for free.